Home » Newsletters » BioWorld Asia

BioWorld Asia

June 20, 2001

View Archived Issues

MelTec, Evotec Form Venture For Drug Discovery, Services

Heat-Shock Proteins Suggest New Mode Of Attack On TB

Cyclacel Raises $47.7M For Cell-Cycle Cancer Programs

Meristem Enters Cystic Fibrosis Licensing Agreement With Solvay

Ethypharm Sets Target Of $137M For IPO in France

Parliament Genetics Debate Takes Pro-Industry Direction

Galapagos, Bayer Enter Deal To Discover Protein Functions

Association Seeks More Options For Biotechnology Product Filings

Other News To Note

DeCODE Enters Monoclonal Antibody Deal With Genmab

Zentaris Cites Market Conditions In Postponing IPO In Germany

Oxford Glyco, Marconi Create Venture For Protein Databases

Amaxas Second Round Nets EUR13M For Transfection Work

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 9, 2025.
In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol
BioWorld
In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
Corestemchemon preps US BLA filing for stem cell ALS therapy
BioWorld
Corestemchemon Inc. is planning to file a BLA for Neuronata-R (lenzumestrocel) by the end of 2025 to gain accelerated approval from the U.S. FDA, company...
Omada, Caris arrivals continue med-tech IPO hot streak
BioWorld MedTech
Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...